Tacrolimus as a single agent facilitates donor engraftment in mice conditioned with 200 or 100 cGy TBI
Reagent . | No. chimeric . | % donor . | Range . |
---|---|---|---|
TBI 200 cGy | |||
Hamster IgG | 0/10 | 0 ± 0 | NA |
Anti-CD40L | 10/104-150 | 69 ± 54-150 | 64 -76 |
Tacrolimus | 5/54-150 | 50 ± 44-150,4-151 | 46 -56 |
Anti-CD40L + tacrolimus | 9/94-150 | 44 ± 64-150,4-151 | 39 -55 |
TBI 100 cGy | |||
Hamster IgG | 0/10 | 0 ± 0 | NA |
Anti-CD40L | 10/104-150 | 50 ± 64-150 | 40 -56 |
Tacrolimus | 10/104-150 | 44 ± 74-150 | 33 -53 |
Anti-CD40L + tacrolimus | 9/94-150 | 42 ± 74-150,4-151 | 28 -50 |
Reagent . | No. chimeric . | % donor . | Range . |
---|---|---|---|
TBI 200 cGy | |||
Hamster IgG | 0/10 | 0 ± 0 | NA |
Anti-CD40L | 10/104-150 | 69 ± 54-150 | 64 -76 |
Tacrolimus | 5/54-150 | 50 ± 44-150,4-151 | 46 -56 |
Anti-CD40L + tacrolimus | 9/94-150 | 44 ± 64-150,4-151 | 39 -55 |
TBI 100 cGy | |||
Hamster IgG | 0/10 | 0 ± 0 | NA |
Anti-CD40L | 10/104-150 | 50 ± 64-150 | 40 -56 |
Tacrolimus | 10/104-150 | 44 ± 74-150 | 33 -53 |
Anti-CD40L + tacrolimus | 9/94-150 | 42 ± 74-150,4-151 | 28 -50 |
B6 mice were irradiated with 200 or 100 cGy TBI as indicated on day − 1 and infused with 40 × 106 BALB/c BM on day 0. Reagents were administered from day − 1 through day 14. PBLs were typed for percentage of donor-host at 3.5 months after BMT. Chimeric is defined as more than 3% donor PBLs. Percentage donor is defined as average percentage donor cells of all mice in the group ± 1 SD. Range indicates lowest to highest level of percentage donor cells in engrafted mice. NA indicates not applicable.
P < .001 compared with hamster IgG.
P ≤ .02 compared with anti-CD40L as a single agent.